(Q43687507)

25 November 2017

Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease (English)

1 reference

25 November 2017

0 references

0 references

1 reference

4

1 reference

25 November 2017

Rajat Sandhir

1

1 reference

25 November 2017

Aarti Yadav

2

1 reference

25 November 2017

Arpit Mehrotra

3

1 reference

25 November 2017

Amandeep Singh

5

1 reference

25 November 2017

Sadhna Sharma

6

1 reference

25 November 2017

6 September 2013

1 reference

25 November 2017

NeuroMolecular Medicine

1 reference

25 November 2017

16

1 reference

25 November 2017

106-118

1 reference

25 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12017-013-8261-y

25 November 2017

0 references

cites work

3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Immediate and delayed treatments with curcumin prevents forebrain ischemia-induced neuronal damage and oxidative insult in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

3-Nitropropionate, the toxic substance of Indigofera , is a suicide inactivator of succinate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Glutathione, iron and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Mitochondria: dynamic organelles in disease, aging, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Expression pattern of ataxia telangiectasia mutated (ATM), p53, Akt, and glycogen synthase kinase-3β in the striatum of rats treated with 3-nitropropionic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Effects of dietary restriction on motor learning and cerebellar noradrenergic dysfunction in aged F344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

The pathophysiology of mitochondrial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Studies on energy-linked reactions: modified mitochondrial ATPase of oligomycin-resistant mutants of Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Impairment of mitochondrial respiration after cerebral hypoxia-ischemia in immature rats: relationship to activation of caspase-3 and neuronal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Advances in nanotechnology-based delivery systems for curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-013-8261-Y

Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.

21 January 2018

1 reference

12 December 2020

A METHOD FOR THE SIMULTANEOUS QUANTITATIVE ESTIMATION OF CYTOCHROMES A, B, C1, AND C IN MITOCHONDRIA

1 reference

12 December 2020

Functional and molecular changes in FoF1 ATP-synthase of cardiac muscle during aging

1 reference

12 December 2020

Biochemical and EPR Probes for Structure-Function Studies of Iron Sulfur Centers of Succinate Dehydrogenase

1 reference

12 December 2020

Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.

1 reference

12 December 2020

Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.

1 reference

12 December 2020

Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.

1 reference

12 December 2020

Some observations on the photometric estimation of mitochondrial volume

1 reference

12 December 2020

Oxidative stress in Huntington's disease

1 reference

12 December 2020

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions

1 reference

12 December 2020

Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc™) in the neuronal cell culture and animal model: implications for Alzheimer's disease

1 reference

12 December 2020

Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles

1 reference

12 December 2020

Determination of carbonyl content in oxidatively modified proteins

1 reference

12 December 2020

Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader

1 reference

12 December 2020

Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS

1 reference

12 December 2020

Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.

1 reference

12 December 2020

Action of caffeine on the spontaneous motility of the mouse

1 reference

12 December 2020

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979.

1 reference

12 December 2020

A fluorometric method for determination of oxidized and reduced glutathione in tissues

1 reference

12 December 2020

Brain imaging and cognitive dysfunctions in Huntington's disease

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease.

1 reference

12 December 2020

Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin

1 reference

12 December 2020

10.1007/S12017-013-8261-Y

Identifiers

DOI

1 reference

25 November 2017

1 reference